Literature DB >> 3871622

Emergency coronary artery bypass surgery after intracoronary thrombolysis for evolving myocardial infarction.

P Kay, A Ahmad, S Floten, A Starr.   

Abstract

Sixteen patients underwent emergency coronary artery bypass surgery immediately after intracoronary streptokinase infusion for acute evolving myocardial infarction. Of these, 11 patients had 70% residual stenosis in the recanalised vessel, and in five thrombolysis was unsuccessful. There were no hospital deaths. All the patients sustained myocardial necrosis, the peak activity of creatine phosphokinase correlating with the time to reperfusion. Chest tube drainage (mean 960 ml) was significantly higher than for control patients but did not correlate with the total dosage of streptokinase. No patients had further myocardial infarction or developed recurrent angina. Selected patients may benefit from coronary bypass surgery after intracoronary streptokinase infusion. If necessary this may be performed immediately with low mortality and morbidity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871622      PMCID: PMC481753          DOI: 10.1136/hrt.53.3.260

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  23 in total

1.  Segmental perfusion of the coronary arteries with fibrinolysin in man following a myocardial infarction.

Authors:  R J BOUCEK; W P MURPHY
Journal:  Am J Cardiol       Date:  1960-08       Impact factor: 2.778

2.  The internal mammary bypass graft: a superior second coronary artery.

Authors:  J W Jones; J L Ochsner; N L Mills; L Hughes
Journal:  J Thorac Cardiovasc Surg       Date:  1978-04       Impact factor: 5.209

3.  Non surgical coronary artery recanalization in acute transmural myocardial infarction.

Authors:  D G Mathey; K H Kuck; V Tilsner; H J Krebber; W Bleifeld
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

4.  Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations.

Authors:  K E Hammermeister; T A DeRouen; H T Dodge
Journal:  Circulation       Date:  1979-03       Impact factor: 29.690

5.  Immediate coronary artery bypass for acute evolving myocardial infarction.

Authors:  R Berg; S L Selinger; J J Leonard; R P Grunwald; W P O'Grady
Journal:  J Thorac Cardiovasc Surg       Date:  1981-04       Impact factor: 5.209

6.  The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.

Authors:  K A Reimer; J E Lowe; M M Rasmussen; R B Jennings
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

7.  Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase.

Authors:  K P Rentrop; H Blanke; K R Karsch; V Wiegand; H Köstering; H Oster; K Leitz
Journal:  Clin Cardiol       Date:  1979-10       Impact factor: 2.882

8.  Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction.

Authors:  J E Markis; M Malagold; J A Parker; K J Silverman; W H Barry; A V Als; S Paulin; W Grossman; E Braunwald
Journal:  N Engl J Med       Date:  1981-10-01       Impact factor: 91.245

9.  Intracoronary thallium 201 scintigraphy as an immediate predictor of salvaged myocardium following intracoronary lysis.

Authors:  H J Krebber; J Schofer; D Mathey; R Montz; P Kalmar; G Rodewald
Journal:  J Thorac Cardiovasc Surg       Date:  1984-01       Impact factor: 5.209

10.  Intracoronary thrombolysis in evolving myocardial infarction.

Authors:  W Ganz; N Buchbinder; H Marcus; A Mondkar; J Maddahi; Y Charuzi; L O'Connor; W Shell; M C Fishbein; R Kass; A Miyamoto; H J Swan
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

View more
  1 in total

1.  Cardiac rupture after thrombolytic therapy: the use of aprotinin to reduce blood loss after surgical repair.

Authors:  C A van Doorn; C M Munsch; J C Cowan
Journal:  Br Heart J       Date:  1992-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.